Showing results (1181-1190 of 5,444) with videos related to
Sort By:
Pageof 545
Bulletin Du Cancer|August 7, 2012
HLA class II susceptibility to cervical cancer among Tunisian womenYosra Ben Othmane, Ezzeddine Ghazouani, Amel Mezlini, et al.Bulletin Du Cancer|September 28, 2012
[Delays in the diagnosis and treatment of lung cancer for patients treated with radiation therapy]Caroline Rivera, Juliette Mathiaux, Thibaud Haaser, et al.Bulletin Du Cancer|September 29, 2012
[Breast cancer follow-up by primary care physician: patient satisfaction in the Metropolitan Paris region]Aurélie Fourcade, Sophie Houzard, Coraline Dubot, et al.Bulletin Du Cancer|September 11, 2012
[Central nervous system complications in patients undergoing cytotoxic chemotherapy and targeted therapies]Dimitri Psimaras, Flavie Bompaire, Hervé Taillia, et al.Bulletin Du Cancer|June 30, 2012
[Cabazitaxel for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: the TROPIC study in France]Damien Pouessel, Stéphane Oudard, Gwenaëlle Gravis, et al.Bulletin Du Cancer|June 30, 2012
[Primary squamous cell carcinoma of the breast: clinical study and review of the literature]Johanna Mychaluk, Marc Baron, Eric Fondrinier, et al.Bulletin Du Cancer|June 21, 2012
[Role of endoscopic ultrasound (EUS) and endobronchial ultrasound (EBUS) for the evaluation of mediastinal adenopathy]Dominique Béchade, François ChomyBulletin Du Cancer|June 21, 2012
Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancerSophie Cousin, Emilie Le Rhun, Audrey Mailliez, et al.Bulletin Du Cancer|January 1, 1990
[Value of clinical tests in the diagnosis of breast cancer: report of 2,626 cases]P Guillet, J M Brandone, R Favre, et al.Bulletin Du Cancer|September 30, 1998
[Histone deacetylase and retinoblastoma protein]L Magnaghi-Jaulin, R Groisman, I Naguibneva, et al.Pageof 545